SpyGlass Pharma, Inc. (SGP) — Defensive Interval Ratio

Latest as of June 2026: 453 days

SpyGlass Pharma, Inc. (SGP) has a Defensive Interval Ratio of 453 days as of June 2026. Defensive assets of $11.72 Million (cash $-, short-term investments $11.04 Million, receivables $678.00K) cover 453 days of daily cash needs of $25.85K/day. See SGP working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

453 days
Days of operational coverage

Defensive Assets

$11.72 Million
Cash + ST Investments + Receivables

Daily Cash Need

$25.85K
Current Liabilities ÷ 365

Current Liabilities

$9.44 Million
USD

SpyGlass Pharma, Inc. Defensive Interval Ratio (2023–2025)

This chart shows how SpyGlass Pharma, Inc.'s Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 453 days, meaning defensive assets of $11.72 Million can fund 453 days of operations without new revenue. Read SpyGlass Pharma, Inc. debt and liabilities for a breakdown of total debt and financial obligations.

Annual Defensive Interval Ratio for SpyGlass Pharma, Inc. (2023–2025)

The table below presents the year-by-year Defensive Interval Ratio for SpyGlass Pharma, Inc. from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see SpyGlass Pharma, Inc. balance sheet assets.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 489 days $11.51 Million $23.52K/day $- $11.08 Million ▲ +489 days
2024 0 days $0.00 $21.35K/day $- $0.00 ▼ -5622 days
2023 5622 days $24.47 Million $4.35K/day $- $24.47 Million —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)